Frexalimab

MedChem Express

Frexalimab

10

Research Use Only

Monoclonal

99.00

Frexalimab (SAR441344) is a second-generation monoclonal antibody targeting the CD40 ligand (CD40L) with a good safety profile. Frexalimab inhibits the binding between CD40 and CD40L to modulate immune response. Frexalimab is likely to help prevent the process of beta-cell destruction. Frexalimab is proming for multiple sclerosis, lupus erythematosus, Sjoegrens syndrome and type I diabetes research [1] [2] [3] [4] [5] .

-80°C

12352203